BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 24, 2004
View Archived Issues
Domantis Raises US$33M For Program In Domain Antibodies
Domantis Ltd. raised US$33 million in a Series B financing that could take the company into clinical trials with its lead domain antibody (dAb) therapeutics. (BioWorld Today)
Read More
FDA Accepts Celgene's sNDA To Broaden Thalomid's Label
Read More
Scripps Scientists Level Synthetic Chemical, Cardiogenol C By Name, From Mouse Stem Cells Into Heart
Read More
Antares Intends To Raise Profile After $14.6M Private Placement
Read More
Other News To Note
Read More